Dale Hsieh
Psychiatry · Austin, TXNPI 1871796607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,349, 6.7 times the $203 reported in 2019.
Across 219 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$834
- Supernus Pharmaceuticals, Inc.$591
- Vanda Pharmaceuticals Inc.$530
- Eisai Inc.$504
- Takeda Pharmaceuticals U.S.A., Inc.$395
- plus $807 from 7 others
What the payments were for
- Food & beverage$4,73399%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $1,137 |
| Otsuka America Pharmaceutical, Inc. | 33 | $834 |
| Supernus Pharmaceuticals, Inc. | 28 | $591 |
| Vanda Pharmaceuticals Inc. | 16 | $530 |
| Eisai Inc. | 26 | $504 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $395 |
| Corium, LLC | 9 | $289 |
| Lundbeck LLC | 14 | $252 |
| Alkermes, Inc. | 11 | $183 |
| Neurocrine Biosciences, Inc. | 1 | $36 |
| Johnson & Johnson | 1 | $17 |
| Neos Therapeutics, LP | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,798 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 47 | $1,154 |
| Carbamazepine | 24 | $447 |
| Escitalopram Oxalate | 71 | $447 |
| Fluvoxamine Maleate | 13 | $376 |
| Bupropion XlBupropion Hcl | 26 | $237 |
| Alprazolam | 26 | $217 |
| Quetiapine Fumarate | 34 | $212 |
| Lamotrigine | 31 | $183 |
| Bupropion Hcl | 11 | $158 |
| Trazodone Hcl | 19 | $109 |
| Haloperidol | 16 | $103 |
| Gabapentin | 35 | $96 |
| Fluoxetine Hcl | 16 | $82 |
| Lithium Carbonate ErLithium Carbonate | 11 | $78 |
| Lorazepam | 19 | $59 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Austin
- Arvinder Pal WaliaAustin$2.5M
- Charles NemeroffAustin$429K
- Divyansu PatelAustin$50K
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.